Literature DB >> 23386109

Role of mesenchymal stem cell-derived microvesicles in tissue repair.

Stefania Bruno1, Giovanni Camussi.   

Abstract

Results from recent studies suggest that the beneficial effect of stem cell-based therapy is mainly dependent on a paracrine effect. The paracrine hypothesis implicates the ability of stem cells to limit injury or coordinate repair through the release of soluble factors. Among these factors microvesicles (MVs) have emerged as a mechanism through which stem cells may reprogram injured cells. In fact, MVs released from stem cells may deliver proteins, bio-active lipids and nucleic acids to injured cells. In particular, the transfer of transcripts derived from stem cells may induce phenotypic and functional changes in the recipient cells that promote the activation of regenerative programs.

Entities:  

Mesh:

Year:  2013        PMID: 23386109     DOI: 10.1007/s00467-013-2413-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  52 in total

1.  Isolation and characterization of a stem cell population from adult human liver.

Authors:  Maria Beatriz Herrera; Stefania Bruno; Stefano Buttiglieri; Ciro Tetta; Stefano Gatti; Maria Chiara Deregibus; Benedetta Bussolati; Giovanni Camussi
Journal:  Stem Cells       Date:  2006-08-31       Impact factor: 6.277

2.  Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury.

Authors:  Ruenn Chai Lai; Fatih Arslan; May May Lee; Newman Siu Kwan Sze; Andre Choo; Tian Sheng Chen; Manuel Salto-Tellez; Leo Timmers; Chuen Neng Lee; Reida Menshawe El Oakley; Gerard Pasterkamp; Dominique P V de Kleijn; Sai Kiang Lim
Journal:  Stem Cell Res       Date:  2010-01-04       Impact factor: 2.020

3.  Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules.

Authors:  H F Heijnen; A E Schiel; R Fijnheer; H J Geuze; J J Sixma
Journal:  Blood       Date:  1999-12-01       Impact factor: 22.113

Review 4.  Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease.

Authors:  Ruenn Chai Lai; Tian Sheng Chen; Sai Kiang Lim
Journal:  Regen Med       Date:  2011-07       Impact factor: 3.806

5.  Endothelial progenitor cell-derived microvesicles improve neovascularization in a murine model of hindlimb ischemia.

Authors:  A Ranghino; V Cantaluppi; C Grange; L Vitillo; F Fop; L Biancone; M C Deregibus; C Tetta; G P Segoloni; G Camussi
Journal:  Int J Immunopathol Pharmacol       Date:  2012 Jan-Mar       Impact factor: 3.219

6.  Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury.

Authors:  Stefano Gatti; Stefania Bruno; Maria Chiara Deregibus; Andrea Sordi; Vincenzo Cantaluppi; Ciro Tetta; Giovanni Camussi
Journal:  Nephrol Dial Transplant       Date:  2011-02-15       Impact factor: 5.992

7.  Stromal cells protect against acute tubular injury via an endocrine effect.

Authors:  Baoyuan Bi; Roland Schmitt; Malika Israilova; Hitoshi Nishio; Lloyd G Cantley
Journal:  J Am Soc Nephrol       Date:  2007-07-26       Impact factor: 10.121

Review 8.  Autologous adipose-derived regenerative cells for therapeutic angiogenesis.

Authors:  Toyoaki Murohara; Satoshi Shintani; Kazuhisa Kondo
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

9.  Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells.

Authors:  Susanna Tomasoni; Lorena Longaretti; Cinzia Rota; Marina Morigi; Sara Conti; Elisa Gotti; Chiara Capelli; Martino Introna; Giuseppe Remuzzi; Ariela Benigni
Journal:  Stem Cells Dev       Date:  2012-12-21       Impact factor: 3.272

10.  Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury.

Authors:  M B Herrera; B Bussolati; S Bruno; L Morando; G Mauriello-Romanazzi; F Sanavio; I Stamenkovic; L Biancone; G Camussi
Journal:  Kidney Int       Date:  2007-05-16       Impact factor: 10.612

View more
  31 in total

1.  Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model.

Authors:  Suyan Bian; Liping Zhang; Liufa Duan; Xi Wang; Ying Min; Hepeng Yu
Journal:  J Mol Med (Berl)       Date:  2013-12-14       Impact factor: 4.599

2.  Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro.

Authors:  Antonella Conforti; Marco Scarsella; Nadia Starc; Ezio Giorda; Simone Biagini; Alessandra Proia; Rita Carsetti; Franco Locatelli; Maria Ester Bernardo
Journal:  Stem Cells Dev       Date:  2014-07-31       Impact factor: 3.272

3.  Mesenchymal stem cells suppress lung inflammation and airway remodeling in chronic asthma rat model via PI3K/Akt signaling pathway.

Authors:  Hai-Yan Lin; Lei Xu; Shuan-Shuan Xie; Fei Yu; Hai-Yang Hu; Xiao-Lian Song; Chang-Hui Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 4.  Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases.

Authors:  Antoine Monsel; Ying-Gang Zhu; Varun Gudapati; Hyungsun Lim; Jae W Lee
Journal:  Expert Opin Biol Ther       Date:  2016-04-12       Impact factor: 4.388

Review 5.  The role of extracellular vesicles in podocyte autophagy in kidney disease.

Authors:  Baichao Sun; Shubo Zhai; Li Zhang; Guangdong Sun
Journal:  J Cell Commun Signal       Date:  2021-02-22       Impact factor: 5.782

Review 6.  Microvesicles as mediators of tissue regeneration.

Authors:  Keith Sabin; Nobuaki Kikyo
Journal:  Transl Res       Date:  2013-10-25       Impact factor: 7.012

Review 7.  The Role of Microvesicles Derived from Mesenchymal Stem Cells in Lung Diseases.

Authors:  Jie Chen; Chonghui Li; Liangan Chen
Journal:  Biomed Res Int       Date:  2015-05-12       Impact factor: 3.411

Review 8.  Stem cell technology for tendon regeneration: current status, challenges, and future research directions.

Authors:  Pauline Po Yee Lui
Journal:  Stem Cells Cloning       Date:  2015-12-11

9.  Autologous mesenchymal stem cell therapy for progressive supranuclear palsy: translation into a phase I controlled, randomized clinical study.

Authors:  Rosaria Giordano; Margherita Canesi; Maurizio Isalberti; Ioannis Ugo Isaias; Tiziana Montemurro; Mariele Viganò; Elisa Montelatici; Valentina Boldrin; Riccardo Benti; Agostino Cortelezzi; Nicola Fracchiolla; Lorenza Lazzari; Gianni Pezzoli
Journal:  J Transl Med       Date:  2014-01-17       Impact factor: 5.531

10.  Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential.

Authors:  Tatiana Lopatina; Stefania Bruno; Ciro Tetta; Natalia Kalinina; Massimo Porta; Giovanni Camussi
Journal:  Cell Commun Signal       Date:  2014-04-11       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.